Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

INTRODUCTION: We compared the economic impacts of linezolid and vancomycin for the treatment of hospitalized patients with methicillin-resistant Staphylococcus aureus (MRSA)–confirmed nosocomial pneumonia. METHODS: We used a 4-week decision tree model incorporating published data and expert opinion...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Dipen A, Shorr, Andrew F, Chastre, Jean, Niederman, Michael, Simor, Andrew, Stephens, Jennifer M, Charbonneau, Claudie, Gao, Xin, Nathwani, Dilip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220084/
https://www.ncbi.nlm.nih.gov/pubmed/25053453
http://dx.doi.org/10.1186/cc13996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220084/
https://www.ncbi.nlm.nih.gov/pubmed/25053453
http://dx.doi.org/10.1186/cc13996

Ejemplares similares